PPARG and metabolic dysfunction-associated steatohepatitis: In this study, the top SNP associated with the achievement of the primary outcome in the pioglitazone-treated patients with NASH was rs4135275, an intronic SNP in PPARG (p = 0.019) (UCSC Genome Browser, 2018).